Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: exercise

Case Report: Acne Drug Leads Patient to Retinoid Hyperostosis

Rachael Stovall, MD, Akira M. Murakami, MD, & Maureen Dubreuil, MD, MSc  |  November 19, 2018

Presentation A 26-year-old man with a history of acne vulgaris and hidradenitis suppurativa presented to our rheumatology clinic with persistent back pain and stiffness of three years’ duration. He described bilateral low back pain that was worse when he arose in the morning and at night when he was trying to sleep. In a similar…

Filed under:Axial SpondyloarthritisConditions Tagged with:Ankylosing SpondylitisisotretinoinRetinoid Hyperostosis

TH Foto-Werbung / Science Source

Turmeric: The Evidence for Therapeutic Use for Arthritis

Samantha C. Shapiro, MD  |  November 19, 2018

During a recent divisional grand rounds presentation, I asked a room full of my colleagues how many of them had been asked about turmeric by a patient within the past year, month, week or day. Most hands remained up by the end of the exercise. During a recent trip to New York City, I was…

Filed under:Drug Updates Tagged with:Turmeric

Is More Better? Weight Loss Analysis in Older Patients with Knee OA

Arthritis Care & Research  |  November 5, 2018

Obesity is a modifiable risk factor for many patients with knee osteoarthritis (OA), and the National Institutes of Health recommend an initial weight loss goal of 10%. But how does losing more weight affect knee OA patients? In a new study, researchers compared the outcomes of knee OA patients who lost more and less than the recommended 10% of their baseline weight, finding significant improvement in health-related quality of life and reduction in pain for patients who lost twice what’s recommended…

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis Care & ResearchkneeKnee Osteoarthritis (OA)Obesityweight loss

How to Engage Young Adult Patients

Carina Stanton  |  October 30, 2018

Gaps in healthcare are common between the ages of 17 and 21. But simple collaborations between adult and pediatric rheumatologists can go a long way to help young adults stay engaged in their rheumatology care…

Filed under:Practice Support Tagged with:Adolescentspatient carePediatric RheumatologyTransitions

ARHP Lifetime Achievement Award Winner: Christina H. Opava, PhD, RPT

Keri Losavio  |  October 22, 2018

CHICAGO—Christina H. Opava, PhD, RPT, is the recipient of the 2018 ARHP Lifetime Achievement Award, which was presented (along with the other ACR and ARHP awards) during the opening session of the 2018 ACR/ARHP Annual Meeting on Oct. 20. “Receiving this award is an immense honor,” she tells The Rheumatologist. “My first thought was that…

Filed under:American College of RheumatologyAwardsMeeting ReportsProfessional TopicsProfiles Tagged with:2018 ACR/ARHP Annual MeetingAssociation of Rheumatology Professionals (ARP)AwardsOpava

8 Ways to Help Your Patients with Medication Costs

Vanessa Caceres  |  October 18, 2018

A patient with rheumatoid arthritis (RA) comes to your office and needs a medication. You prescribe it, and the patient’s insurance plan covers it. The patient begins the medication and slowly but surely feels better. Prescribing drugs for a patient should be this simple but rarely is, thanks to the high cost of drugs and…

Filed under:Drug UpdatesPatient PerspectivePractice Support Tagged with:cost savingdrug costs

Study Sees Improvement in OA Patients Who Received Ayurvedic Therapy

Elizabeth Hofheinz, MPH, MEd  |  October 18, 2018

Mounting evidence suggests that humans have a complex and integrated mind-body system. Knee problems may affect the spine and other body parts, but also the mind—and vice versa. This is the wisdom of Ayurveda, the 3,000-year-old traditional medicine from India. A team of researchers from Germany recently undertook a study, titled “Effectiveness of an Ayurveda…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:AyurvedaAyurvedic therapymind-body therapy

Collaborative Interventions Can Improve Sjögren Syndrome Patients’ Daily Lives

Carina Stanton  |  September 27, 2018

New research identifies how education designed to empower self-care and collaboration among providers, patients and family members can help patients with Sjögren’s syndrome manage their daily challenges and take back their lives…

Filed under:ConditionsSjögren’s Disease Tagged with:communicationpatient carephysician-patient communicationSjogren's

FDA Issues Safety Warning

Michele B. Kaufman, PharmD, BCGP  |  September 25, 2018

The FDA is warning that patients with type 2 diabetes taking SGLT2 inhibitors may be at risk of developing a rare, serious infection, Fournier’s gangrene…

Filed under:Drug Updates Tagged with:Drug SafetyFDAFournier’s gangreneInfectionSGLT2 inhibitorssodium-glucose cotransporter-2 (SGLT2) inhibitorsU.S. Food and Drug Administration (FDA)

Immune Checkpoint Inhibitors & Immune-Related Adverse Events

Priya Chokshi, MD, Roberta Seidman, MD, Noah Levit, PhD, MD, & Steven E. Carsons, MD  |  September 20, 2018

Immune checkpoint inhibitors (ICIs) are at the forefront of advances in cancer therapy and have shown promising results for progression-free survival. Checkpoint signaling pathways, such as cytotoxic T-lymphocyte antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1), normally regulate the immune response to promote self-tolerance and prevent tissue damage and inflammation. PD-1 is a…

Filed under:ConditionsDrug UpdatesMyositisOther Rheumatic Conditions Tagged with:immune-related adverse eventsirAEsmyositisnivolumab

  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 77
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences